{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:53:56Z","timestamp":1792007636121,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02424-6","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:46:07Z","timestamp":1784781967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fasting insulin to HDL-C ratio is correlated with MASLD severity in Chinese overweight\/obesity: a cross-sectional analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaojuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xincheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2424_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol metabolism. 2024;35:697\u2013707.","journal-title":"Trends Endocrinol metabolism"},{"key":"2424_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology. 2020;71:1851.","journal-title":"Hepatology"},{"key":"2424_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8:20\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2424_CR4","doi-asserted-by":"crossref","unstructured":"Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the american heart association. Arterioscler Thromb Vasc Biol. 2022;42:e168-e185.","DOI":"10.1161\/ATV.0000000000000153"},{"key":"2424_CR5","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107 E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metab Clin Exp. 2021;119:154770.","journal-title":"Metab Clin Exp"},{"key":"2424_CR6","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Paik JM, Al Shabeeb R, Golabi P, Younossi I, Henry L. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology (Baltimore, Md.). 2022;76:1423\u201337.","DOI":"10.1002\/hep.32499"},{"key":"2424_CR7","doi-asserted-by":"crossref","unstructured":"Khan RS, Bril F, Cusi K, Newsome PN. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 2019;70:711\u201324.","DOI":"10.1002\/hep.30429"},{"key":"2424_CR8","doi-asserted-by":"crossref","unstructured":"Shuwei H, Yingjie A, Chencheng H, Fathima NCB, Yanyong X. Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications. Genes & Dis. 2024;12.","DOI":"10.1016\/j.gendis.2024.101372"},{"key":"2424_CR9","doi-asserted-by":"publisher","first-page":"e3736","DOI":"10.1002\/dmrr.3736","volume":"40","author":"G Petralli","year":"2024","unstructured":"Petralli G, Salvati A, Tric\u00f2 D, Ricco G, Colombatto P, Brunetto MR, et al. Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease. Diab\/Metab Res Rev. 2024;40:e3736.","journal-title":"Diab\/Metab Res Rev"},{"key":"2424_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5152\/tjg.2018.18237","volume":"30","author":"KN Elfayoumy","year":"2019","unstructured":"Elfayoumy KN, Berengy MS, Emran T. Insulin\/high-density lipoprotein cholesterol ratio: A newly discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus. Turkish J Gastroenterol. 2019;30:155\u201362.","journal-title":"Turkish J Gastroenterol"},{"key":"2424_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/ijms25021109","volume":"25","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen R. The Role of SCAP\/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis. Int J Mol Sci. 2024;25:1109.","journal-title":"Int J Mol Sci"},{"key":"2424_CR12","doi-asserted-by":"crossref","unstructured":"D E. Deciphering the molecular pathways of saroglitazar: A dual PPAR \u03b1\/\u03b3 agonist for managing metabolic NAFLD. Metabolism: Clin Exp. 2024;155.","DOI":"10.1016\/j.metabol.2024.155912"},{"key":"2424_CR13","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.3168\/jds.2022-22895","volume":"106","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Lei L, Wang X, Jiang Q, Loor JJ, Kong F, et al. Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver. J Dairy Sci. 2023;106:5626\u201335.","journal-title":"J Dairy Sci"},{"key":"2424_CR14","doi-asserted-by":"crossref","unstructured":"Li J, Xie S, Teng W. Sulforaphane attenuates nonalcoholic fatty liver disease by inhibiting hepatic steatosis and apoptosis. Nutrients. 2021;14:76.","DOI":"10.3390\/nu14010076"},{"key":"2424_CR15","doi-asserted-by":"publisher","first-page":"e00854","DOI":"10.1002\/advs.202500854","volume":"12","author":"C Xu","year":"2025","unstructured":"Xu C, Zhu H, Wang K, Hu H, Wei X, Xu D, et al. Oral Celastrol Micelles Forming High-Density Lipoprotein Corona Targeting Hepatocytes for MASLD Treatment. Adv Sci. 2025;12:e00854.","journal-title":"Adv Sci"},{"key":"2424_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13098-024-01457-y","volume":"16","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chang D, Guan Q, Dong R, Zhang R, Zhang W, et al. High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study. Diabetol Metab Syndr. 2024;16:223.","journal-title":"Diabetol Metab Syndr"},{"key":"2424_CR17","doi-asserted-by":"crossref","unstructured":"Bril F, Pearce RW, Collier TS, McPhaul MJ. Differences in HDL-Bound apolipoproteins in patients with advanced liver fibrosis due to nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2022;108.","DOI":"10.1210\/clinem\/dgac565"},{"key":"2424_CR18","doi-asserted-by":"crossref","unstructured":"Zvintzou E, Xepapadaki E, Skroubis G, Mparnia V, Giannatou K, Benabdellah K, et al. High-density lipoprotein in metabolic disorders and beyond: an exciting new world full of challenges and opportunities. Pharmaceuticals. 2023;16(6):855.","DOI":"10.3390\/ph16060855"},{"key":"2424_CR19","doi-asserted-by":"publisher","first-page":"100402","DOI":"10.1016\/j.metop.2025.100402","volume":"28","author":"XX Tang","year":"2025","unstructured":"Tang XX, Wu R, Chen JH, Wang FL, Zhao SL, Lu J, et al. Association between HOMA-IR and metabolic dysfunction-associated steatohepatitis in U.S. adults with MASLD. Metabolism Open. 2025;28:100402.","journal-title":"Metabolism Open"},{"key":"2424_CR20","doi-asserted-by":"publisher","first-page":"101345","DOI":"10.1016\/j.diabet.2022.101345","volume":"48","author":"B Rivi\u00e8re","year":"2022","unstructured":"Rivi\u00e8re B, Jaussent A, Macioce V, Faure S, Builles N, Lefebvre P, et al. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. Diabetes Metab. 2022;48:101345.","journal-title":"Diabetes Metab"},{"key":"2424_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12902-024-01794-z","volume":"24","author":"J Tian","year":"2024","unstructured":"Tian J, Cao Y, Zhang W, Wang A, Yang X, Dong Y, et al. The potential of insulin resistance indices to predict non-alcoholic fatty liver disease in patients with type 2 diabetes. BMC Endocr Disorders. 2024;24:261.","journal-title":"BMC Endocr Disorders"},{"key":"2424_CR22","doi-asserted-by":"crossref","unstructured":"Ma X, Jiang X, Gao G, Ban B, Sheng J, Shi S, et al. Association of conventional and unconventional lipid profiles with visceral fat area in overweight\/obese individuals with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2025;18:1025-1034.","DOI":"10.2147\/DMSO.S506490"},{"key":"2424_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ, Paredes A, Boursier J, Chan WK, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020;5:362\u201373.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2424_CR24","first-page":"494","volume":"27","author":"JG Fan","year":"2024","unstructured":"Fan JG, Xu XY, Nan YM, Wei L, Jia JD, Zhuang H, et al. Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024). Chin J Hepatol. 2024;27:494\u2013510.","journal-title":"Chin J Hepatol"},{"key":"2424_CR25","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, De L\u00e9dinghen V, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022\u201330.","journal-title":"J Hepatol"},{"key":"2424_CR26","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022;71:1006\u201319.","journal-title":"Gut"},{"key":"2424_CR27","first-page":"90","volume":"16","author":"Department of Medical Administration, National Health Commission of the People\u2019s Republic of China","year":"2025","unstructured":"Department of Medical Administration, National Health Commission of the People\u2019s Republic of China. Chinese Guidelines for the Clinical Management of Obesity (2024 Edition). Med J Peking Union Med Coll Hosp. 2025;16:90\u2013108.","journal-title":"Med J Peking Union Med Coll Hosp"},{"key":"2424_CR28","first-page":"49","volume-title":"Hepatic steatosis is associated with anthropometry, cardio-metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans","author":"SE Kastberg","year":"2022","unstructured":"Kastberg SE, Lund HS, De Lucia-Rolfe E, Kaduka LU, Boit MK, Corpeleijn E, et al. Hepatic steatosis is associated with anthropometry, cardio-metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans. Volume 27. Tropical medicine & international health: TM & IH; 2022. pp. 49\u201357."},{"key":"2424_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13293-022-00475-7","volume":"13","author":"S Fresneda","year":"2022","unstructured":"Fresneda S, Abbate M, Busquets-Cort\u00e9s C, L\u00f3pez-Gonz\u00e1lez A, Fuster-Parra P, Bennasar-Veny M, et al. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study. Biology Sex Differences. 2022;13:64.","journal-title":"Biology Sex Differences"},{"key":"2424_CR30","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48:S27\u201349.","journal-title":"Diabetes Care"},{"key":"2424_CR31","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/hepr.12656","volume":"46","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features. Hepatol Res. 2016;46:1074\u201387.","journal-title":"Hepatol Res"},{"key":"2424_CR32","doi-asserted-by":"publisher","first-page":"964","DOI":"10.4093\/dmj.2025.0644","volume":"49","author":"XT Truong","year":"2025","unstructured":"Truong XT, Lee DH. Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications. Diabetes Metabolism J. 2025;49:964\u201386.","journal-title":"Diabetes Metabolism J"},{"key":"2424_CR33","doi-asserted-by":"publisher","first-page":"156511","DOI":"10.1016\/j.metabol.2026.156511","volume":"177","author":"Y Liu","year":"2026","unstructured":"Liu Y, Pang J, Ma M, Xu P, Tang Z, Guo Y, et al. Natural polyketide enterocin inhibits ASGR1 to enhance cholesterol efflux and regulate hepatic lipid metabolism. Metab Clin Exp. 2026;177:156511.","journal-title":"Metab Clin Exp"},{"key":"2424_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev.me.44.020193.001005","volume":"44","author":"GM Reaven","year":"1993","unstructured":"Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121\u201331.","journal-title":"Annu Rev Med"},{"key":"2424_CR35","doi-asserted-by":"publisher","first-page":"9191","DOI":"10.3390\/ijms26189191","volume":"26","author":"JAMJL Janssen","year":"2025","unstructured":"Janssen JAMJL. The Pivotal Role of the Western Diet, Hyperinsulinemia, Ectopic Fat, and Diacylglycerol-Mediated Insulin Resistance in Type 2 Diabetes. Int J Mol Sci. 2025;26:9191.","journal-title":"Int J Mol Sci"},{"key":"2424_CR36","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.jnutbio.2023.109452","volume":"122","author":"Y Gong","year":"2023","unstructured":"Gong Y, Lu Q, Xi L, Liu Y, Yang B, Su J, et al. F6P\/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish. J Nutr Biochem. 2023;122:109452.","journal-title":"J Nutr Biochem"},{"key":"2424_CR37","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.3390\/ijms25105066","volume":"25","author":"JDM Santos","year":"2024","unstructured":"Santos JDM, Silva JFT, Alves EDS, Cruz AG, Santos ARM, Camargo FN, et al. Strength Training Protects High-Fat-Fed Ovariectomized Mice against Insulin Resistance and Hepatic Steatosis. Int J Mol Sci. 2024;25:5066.","journal-title":"Int J Mol Sci"},{"key":"2424_CR38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","volume":"83","author":"GR Steinberg","year":"2025","unstructured":"Steinberg GR, Valvano CM, De Nardo W, Watt MJ. Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms. J Hepatol. 2025;83:584\u201395.","journal-title":"J Hepatol"},{"key":"2424_CR39","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","volume":"158","author":"V Azzu","year":"2020","unstructured":"Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease. Gastroenterology. 2020;158:1899\u2013912.","journal-title":"Gastroenterology"},{"key":"2424_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12719","volume":"283","author":"P Dongiovanni","year":"2018","unstructured":"Dongiovanni P, Stender S, Pietrelli A, Mancina RM, Cespiati A, Petta S, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2018;283:356\u201370.","journal-title":"J Intern Med"},{"key":"2424_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2025.11.015","volume":"38","author":"F Di Pastena","year":"2026","unstructured":"Di Pastena F, Gautam J, Lally JSV, Fayyazi R, Grasset E, Bhattacharya D, et al. Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH. Cell Metabol. 2026;38:33\u2013e4910.","journal-title":"Cell Metabol"},{"key":"2424_CR42","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1038\/s41467-020-19668-y","volume":"11","author":"H Xu","year":"2020","unstructured":"Xu H, Zhao Q, Song N, Yan Z, Lin R, Wu S, et al. AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis. Nat Commun. 2020;11:5807.","journal-title":"Nat Commun"},{"key":"2424_CR43","doi-asserted-by":"publisher","first-page":"124419","DOI":"10.1016\/j.lfs.2026.124419","volume":"397","author":"SH Tsou","year":"2026","unstructured":"Tsou SH, Chen WL, Liao CC, Lin SC, Wang CC, Weng LH, et al. miR-302 protects the liver from glucolipotoxicity-induced lipid accumulation through activating AMPK and suppressing Elovl6 in HepG2 cells and also in mice. Life Sci. 2026;397:124419.","journal-title":"Life Sci"},{"key":"2424_CR44","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology (Baltimore MD). 2010;52:1836\u201346.","journal-title":"Hepatology (Baltimore MD)"},{"key":"2424_CR45","doi-asserted-by":"publisher","first-page":"e2310443","DOI":"10.1002\/adma.202310443","volume":"36","author":"Y Bai","year":"2024","unstructured":"Bai Y, Chen J, Zhang S, Xu G, Mao Z, Ding Y, et al. Inflammation-Responsive Cell Membrane-Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative Stress. Adv Mater. 2024;36:e2310443.","journal-title":"Adv Mater"},{"key":"2424_CR46","doi-asserted-by":"publisher","first-page":"115165","DOI":"10.1016\/j.celrep.2024.115165","volume":"44","author":"S Zhao","year":"2025","unstructured":"Zhao S, Zhu Q, Lee WH, Funcke JB, Zhang Z, Wang MY, et al. The adiponectin-PPAR\u03b3 axis in hepatic stellate cells regulates liver fibrosis. Cell Rep. 2025;44:115165.","journal-title":"Cell Rep"},{"key":"2424_CR47","doi-asserted-by":"crossref","unstructured":"Kim KE, Lee J, Shin HJ, Jeong EA, Jang HM, Ahn YJ, et al. Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob\/Ob mice. Hepatology. 2023;77:888\u2013901.","DOI":"10.1002\/hep.32569"},{"key":"2424_CR48","doi-asserted-by":"publisher","first-page":"101039","DOI":"10.1016\/j.crfs.2025.101039","volume":"10","author":"D Mun","year":"2025","unstructured":"Mun D, Ryu S, Lee DJ, Kwak MJ, Choi H, Kang AN, et al. Bovine colostrum-derived extracellular vesicles protect against non-alcoholic steatohepatitis by modulating gut microbiota and enhancing gut barrier function. Curr Res Food Sci. 2025;10:101039.","journal-title":"Curr Res Food Sci"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02424-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:37:39Z","timestamp":1788406659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02424-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2424"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02424-6","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Tianjin Union Medical Center (NO.2021C06). All participants signed a written informed consent prior to participation. The study complied with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"251"}}